I am not saying you are wrong. I could argue REMS may be an incentive for doctors more willing to prescribe Qsymia as their liability may be reduced. But no one knows the real effect this REMS may be until we have sometime to see it & one year is a reasonable time. I actually own both ARNA & VVUS but for very different reason.